IN VIVO

Join Vermon at WHX 2026, in Dubai, UAE, from February 9 to February 12, North Hall 21, K.92.

Vermon has been awarded the EcoVadis Gold Medal 2025 for the second consecutive year, recognizing its strong commitment to Corporate Social Responsibility. This distinction places Vermon among the top 5% of companies worldwide, highlighting its continuous efforts in sustainability, ethics, and responsible business practices.

Vermon has been awarded the INPI Export Award 2025, recognizing the strength of our intellectual property strategy and its role in supporting the international development of our high-performance ultrasound technologies. This distinction highlights Vermon’s contribution to French medical innovation and its global impact in the field of medical ultrasound and diagnostic imaging.

The POCUSI (Point of Care UltraSound for Screening & Intervention) consortium—bringing together E-Scopics, Vermon, IHU Strasbourg, and Inria—has been awarded funding under the France 2030 investment plan to develop a new generation of software-based, intelligent, and frugal ultrasound imaging devices.

With a total budget of €6.7 million over five years, the project aims to democratize point-of-care ultrasound, making advanced imaging accessible to non-expert operators throughout the patient care pathway. POCUSI focuses particularly on chronic liver diseases and metabolic disorders, enabling improved screening, monitoring, and image-guided interventions. By combining cutting-edge software, high-performance probes, clinical expertise, and data-driven simulation tools, POCUSI supports the emergence of a strategic and sustainable French digital ultrasound sector, strengthening France’s technological sovereignty in medical imaging.

Join Vermon at RSNA 2025 in Chicago, USA, from November 30 to December 4. Discover our latest ultrasound transducer innovations and meet our team in North Hall, Level 3 – Booth 8049.